Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Stuckert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Contact Dermatitis|December 17, 2008
Low-cobalt diet for dyshidrotic eczema patientsJoseph Stuckert, Susan Nedorost
Dermatitis : Contact, Atopic, Occupational, Drug|October 6, 2010
Shiitake mushroom dermatitisSean Carlson, Joseph Stuckert, Susan Nedorost
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694Ahmad A Tarhini, Joseph Stuckert, Sandra Lee, et al.
Melanoma Research|February 11, 2014
Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfaAhmad A Tarhini, Donghoon Shin, Sandra J Lee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Contact Dermatitis|December 17, 2008
Low-cobalt diet for dyshidrotic eczema patientsJoseph Stuckert, Susan Nedorost
Dermatitis : Contact, Atopic, Occupational, Drug|October 6, 2010
Shiitake mushroom dermatitisSean Carlson, Joseph Stuckert, Susan Nedorost
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694Ahmad A Tarhini, Joseph Stuckert, Sandra Lee, et al.
Melanoma Research|February 11, 2014
Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfaAhmad A Tarhini, Donghoon Shin, Sandra J Lee, et al.
Pageof 1